NCT02148263

Brief Summary

Eye care professionals prescribe contact lenses to new wearers on a daily basis, and it is common practice for practitioners to educate their patients to gradually increase their contact lens wear time over their first few days of use; however, there is no scientific basis in the literature for this practice. This study will compare the ocular health and comfort of new contact lens wearers who are randomly assigned to begin contact lens wear with increasing wearing time versus those who immediately start full-time wear (eight hours or more/day). The increasing wearing time group will wear daily wear contact lenses (Acuvue Oasys) for two, four, six, eight, and eight or more hours on the first, second, third, fourth, and fifth days, respectively. The other group will be instructed to wear the same contact lenses for eight or more hours per day, starting with the first day of wear. Both groups of subjects will have their eye health and comfort evaluated at baseline, one, and two weeks with a lighted-microscope and eye comfort surveys. Subjects will also keep a daily log of eye comfort with a visual analog scale survey at home. All subjects will learn how to wear and take care of contact lenses. They will also receive a prescription for contact lenses at the conclusion if they wish to continue wearing the study contact lenses.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2014

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

May 21, 2014

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 28, 2014

Completed
5.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 20, 2019

Completed
14 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 3, 2019

Completed
3 years until next milestone

Results Posted

Study results publicly available

August 22, 2022

Completed
Last Updated

September 29, 2022

Status Verified

September 1, 2022

Enrollment Period

5.3 years

First QC Date

May 21, 2014

Results QC Date

April 6, 2021

Last Update Submit

September 19, 2022

Conditions

Keywords

Contact LensesNeophytesContact Lens AdaptationRandomized

Outcome Measures

Primary Outcomes (1)

  • Between-Group Difference in Eye Comfort as Measured by the Ocular Surface Disease Index (OSDI)

    This is an eye comfort survey. The Ocular Surface Disease Index (OSDI) is assessed on a scale of 0 to 100, with higher scores representing greater disability. The index demonstrates sensitivity and specificity in distinguishing between normal subjects and patients with dry eye disease. The OSDI is a valid and reliable instrument for measuring dry eye disease (normal, mild to moderate, and severe) and effect on vision-related function.

    2 weeks

Secondary Outcomes (9)

  • Between-Group Difference in Visual Acuity as Measured With the Bailey-Lovie Chart

    2 weeks

  • Between-Group Difference in Tear Stability as Measured by Non-Invasive Break Up Time (NIBUT)

    2 Weeks

  • Between-Group Difference in Tear Volume as Measured by Tear Meniscus Height (TMH)

    2 Weeks

  • Between-Group Difference in Bulbar Conjunctival Redness as Measured With the Keratograph 5M

    2 Weeks

  • Between-Group Difference in Upper and Lower Eyelid Blepharitis

    2 Weeks

  • +4 more secondary outcomes

Study Arms (2)

Full-Time Senofilcon A Contact Lens Wear

EXPERIMENTAL

This group will start wearing contact lenses 8 or more hours per day on the first day of wear

Device: senofilcon A

Graduated Senofilcon A Contact Lens Wear

EXPERIMENTAL

This group will start wearing contact lenses on a graduated schedule (day 1 = 2 hours, day 2 = 4 hours, day 3 = 6 hours, day 4 = 8 hours, day 5 = 8 or more hours).

Device: senofilcon A

Interventions

Also known as: Acuvue Oasys
Full-Time Senofilcon A Contact Lens WearGraduated Senofilcon A Contact Lens Wear

Eligibility Criteria

Age8 Years+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Has had a completed comprehensive eye exam within the past 6 months
  • Able to wear spherical senofilcon A contact lenses
  • Able to use Opti-Free PureMoist contact lens solution

You may not qualify if:

  • Any prior contact lens use
  • Topical eye drops within the last two hours of the study visit
  • Known systemic health conditions known to alter tear film physiology
  • History of severe ocular trauma
  • Active ocular infection
  • Active ocular inflammation
  • Known hypersensitivity to diagnostic eye drops
  • Pregnant or breast feeding

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Ohio State University

Columbus, Ohio, 43210, United States

Location

Related Publications (9)

  • Sullivan BD, Whitmer D, Nichols KK, Tomlinson A, Foulks GN, Geerling G, Pepose JS, Kosheleff V, Porreco A, Lemp MA. An objective approach to dry eye disease severity. Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6125-30. doi: 10.1167/iovs.10-5390. Epub 2010 Jul 14.

    PMID: 20631232BACKGROUND
  • Sullivan BD, Crews LA, Sonmez B, de la Paz MF, Comert E, Charoenrook V, de Araujo AL, Pepose JS, Berg MS, Kosheleff VP, Lemp MA. Clinical utility of objective tests for dry eye disease: variability over time and implications for clinical trials and disease management. Cornea. 2012 Sep;31(9):1000-8. doi: 10.1097/ICO.0b013e318242fd60.

    PMID: 22475641BACKGROUND
  • Bron AJ, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea. 2003 Oct;22(7):640-50. doi: 10.1097/00003226-200310000-00008.

    PMID: 14508260BACKGROUND
  • Yang SN, Tai YC, Sheedy JE, Kinoshita B, Lampa M, Kern JR. Comparative effect of lens care solutions on blink rate, ocular discomfort and visual performance. Ophthalmic Physiol Opt. 2012 Sep;32(5):412-20. doi: 10.1111/j.1475-1313.2012.00922.x. Epub 2012 Jul 7.

    PMID: 22775005BACKGROUND
  • Dougherty BE, Nichols JJ, Nichols KK. Rasch analysis of the Ocular Surface Disease Index (OSDI). Invest Ophthalmol Vis Sci. 2011 Nov 7;52(12):8630-5. doi: 10.1167/iovs.11-8027.

    PMID: 21948646BACKGROUND
  • Chalmers RL, Begley CG. Dryness symptoms among an unselected clinical population with and without contact lens wear. Cont Lens Anterior Eye. 2006 Mar;29(1):25-30. doi: 10.1016/j.clae.2005.12.004. Epub 2006 Jan 31.

    PMID: 16448840BACKGROUND
  • Faber E, Golding TR, Lowe R, Brennan NA. Effect of hydrogel lens wear on tear film stability. Optom Vis Sci. 1991 May;68(5):380-4. doi: 10.1097/00006324-199105000-00010.

    PMID: 1852401BACKGROUND
  • Efron N, Morgan PB, Katsara SS. Validation of grading scales for contact lens complications. Ophthalmic Physiol Opt. 2001 Jan;21(1):17-29.

    PMID: 11220037BACKGROUND
  • Pucker AD, Steele K, Rueff E, Franklin QX, McClure K, Savla K, Walline JJ. Contact Lens Adaption in Neophytes. Optom Vis Sci. 2021 Mar 1;98(3):266-271. doi: 10.1097/OPX.0000000000001662.

Limitations and Caveats

There was a data collection error, which prevented the study from analyzing CLDEQ-8 scores. This study also intended to included conjunctival staining with lissamine green; however, lissamine green was not available during the conduct of this study, so this outcome was not included.

Results Point of Contact

Title
Dr. Andrew Pucker
Organization
The University of Alabama at Birmingham

Study Officials

  • Andrew D Pucker, OD, MS

    Ohio State University

    PRINCIPAL INVESTIGATOR
  • Jeffrey J Walline, OD, PhD

    Ohio State University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Research Associate

Study Record Dates

First Submitted

May 21, 2014

First Posted

May 28, 2014

Study Start

May 1, 2014

Primary Completion

August 20, 2019

Study Completion

September 3, 2019

Last Updated

September 29, 2022

Results First Posted

August 22, 2022

Record last verified: 2022-09

Locations